Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-12-063321
Filing Date
2012-09-13
Accepted
2012-09-13 16:58:43
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a12-14019_310qa.htm 10-Q/A 29036
  Complete submission text file 0001104659-12-063321.txt   26820195

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT anpi-20120630.xml EX-101.INS 6647311
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anpi-20120630.xsd EX-101.SCH 104677
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anpi-20120630_cal.xml EX-101.CAL 105548
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anpi-20120630_def.xml EX-101.DEF 605267
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anpi-20120630_lab.xml EX-101.LAB 1376864
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anpi-20120630_pre.xml EX-101.PRE 775468
Mailing Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6 604-221-7676
ANGIOTECH PHARMACEUTICALS INC (Filer) CIK: 0001096481 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-30334 | Film No.: 121090633
SIC: 3841 Surgical & Medical Instruments & Apparatus